Recent news on

Lundbeck Q1 opg profit increases 46 pct to 658 mln dkr, beats ...  -  May 9, 2007
Forbes,...'The group's pharmaceuticals Cipralex and Ebixa (for the treatment of depression and Alzheimer's disease respectively) continued to grow combined with the

Alzheimer's Society NICE Challenge Submitted To High Court, UK  -  Apr 30, 2007
Medical News Today (press release),...ruled four drug treatments licensed for Alzheimer's disease (Aricept, Exelon, Reminyl and Ebixa) should no longer be funded by the NHS.

Nice challenge submitted to High Court  -  Apr 27, 2007
Craegmoor News (press release),Earlier this year, Nice hit the headlines by declaring that it would limit the amount of Aricept, Exelon, Reminyl and Ebixa made available for the price of

Pharma tells Parliament about the problems with NICE  -  May 21, 2007
Pharma Times (subscription),...the condition - Pfizer/Eisai's Aricept (donepezil), Novartis' Exelon (rivastigmine), Shire's Reminyl (galantamine) and Lundbeck's Ebixa (memantine).

`Playing God,' UK Denies Cancer Drugs, Patients Say (Update2)  -  May 17, 2007
BloombergLundbeck's Ebixa for mild Alzheimer's disease is routinely provided by some regional NHS authorities, company spokeswoman Jenny Harte said.

Pharma Sector: Few Newsmakers Of The Week - Pharmaxis, Celgene ...  -  May 19, 2007
Trading Markets,In March 2005, NICE recommended for the withdrawal of Aricept, Exelon, Reminyl and Ebixa, the only drugs licensed in Britain for the treatment of

Banned Alzheimer drugs are better than we thought  -  May 14, 2007
Daily Mail,It also ruled that the drug Ebixa should be used only in clinical studies. The rationing body said the drugs "did not make enough of a difference for us to

Earnings shoot up at Denmark's Lundbeck as Lexapro sales soar  -  May 10, 2007
Pharma Times (subscription),The Alzheimer's disease drug Ebixa (memantine) climbed 26% to 391 million kroner and two of the firm's newer products - Azilect (rasagiline) for Parkinson's

Alzheimer's drug could help my wife  -  Apr 4, 2007
Therapeutics Daily (subscription) (press release),But a drug called Memantine, or Ebixa, can temporarily slow down the progression of symptoms. Mr Welling said that the cost of a year's worth of the drug

Please let my wife have drug  -  Apr 4, 2007
Therapeutics Daily (subscription) (press release),Bryan Welling, of St George, says memantine, or Ebixa, costs £2.50 a day - and that the cost of prescribing it for a whole year is less than just a week of

Care centre for dementia patients axed  -  Apr 2, 2007
Norwich Evening News,Funding for Alzheimer's drugs such as Aricept, Riminyl and Ebixa, which amounts to £2.50 a day, have also been cut by Nice.

Review of Alzheimer's drugs' ruling  -  27 Mar 2007
Channel 4 News,Another drug, Ebixa (memantine), is only to be used in clinical studies for people with moderately severe to severe Alzheimer's disease.

Lundbeck profits down but Cipralex sales continue to soar  -  Mar 8, 2007
Pharma Times (subscription),Sales of Lundbeck's own Cipralex brand of the antidepressant advanced 34% to 3.51 billion kroner, while Alzheimer's disease drug Ebixa (memantine) climbed

Alzheimer's sufferers lose £500000 drug cash in court fight  -  Mar 1, 2007
This is London,A fourth, Ebixa, is banned for all. The Alzheimer's Society says the restrictions will mean patients are denied drugs at the time they could most benefit

Alzheimer's patients overpaying for drugs  -  Mar 1, 2007
Daily Mail,Another drug Ebixa, which is licensed for late-stage dementia, can be used only in clinical trials. NICE accepts the drugs are effective, but claims they

Mail launches campaign to end restrictions on Alzheimer's drugs  -  Feb 26, 2007
This is London,Only patients with 'moderate' symptoms are eligible for these medicines, while a new drug called Ebixa which improves severe behavioural problems can be

Lundbeck USA to Establish US Headquarters in Philadelphia Pennsylvania  -  Feb 19, 2007
Expansion Management,Lundbeck A/SH Lundbeck A/S, and its partners develop, license, and market such psychiatric and neurological drugs such as Lexapro, Azilect, and Ebixa.

Drug Firm To Bring Jobs To Region  -  Feb 9, 2007
Chester Daily Local Online,...company H. Lundbeck A/S. It and its partners develop, license, and market psychiatric and neurological drugs such as Lexapro, Azilect, and Ebixa.

Lundbeck USA Signs Lease Agreement to Establish US Headquarters in ...  -  Feb 8, 2007
Genetic Engineering News (press release),...license, and market some of the worlds most innovative and relied upon psychiatric and neurological drugs such as Lexapro(R), Azilect(R), and Ebixa(R).

Lundbeck USA Signs Lease Agreement to Establish US Headquarters in ...  -  Feb 8, 2007
Business Wire (press release),...license, and market some of the worlds most innovative and relied upon psychiatric and neurological drugs such as Lexapro®, Azilect®, and Ebixa®.

Lundbeck sets up Israeli drug discovery task force  -  Feb 8, 2007
Globes,Lundbeck has developed a number of well-known drugs among them Cipralex, and Ebixa. Lundbeck is now looking for new products for the treatment of central

Campaigners back court challenge on Alzheimer's drug  -  Feb 7, 2007
Norwich Evening News,There are more than 13000 people living in Norfolk with dementia, but Nice has cut funding for Aricept, Riminyl and Ebixa, which amounts to £2.50 a day.

Alzheimer's disease: physicians do not always practice what NICE ...  -  Feb 5, 2007
Pharmaceutical Business Review...(rivastigmine) and Razadyne (galantamine), or the NMDA antagonist memantine, which is branded as Namenda and Ebixa in the US and Europe respectively.

TODAY ON PHARMALIVE.COM  -  Dec 19, 2006
PharmaLive.com (press release),...the use of the NMDA receptor antagonist Namenda/Ebixa (Forest/Lundbeck) is gaining acceptance, particularly in the treatment of moderate to severe AD.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional